This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1992 Feb 1;304(6822):319.

doi: 10.1136/bmj.304.6822.319-b.

High potency factor VIII concentrates

PMID: 1739845
PMCID: PMC1881080
DOI: 10.1136/bmj.304.6822.319-b

Comment

High potency factor VIII concentrates

E E Mayne. BMJ. 1992.

. 1992 Feb 1;304(6822):319.

doi: 10.1136/bmj.304.6822.319-b.

Author

PMID: 1739845
PMCID: PMC1881080
DOI: 10.1136/bmj.304.6822.319-b

No abstract available

PubMed Disclaimer

Comment in

High purity factor VIII concentrates and HIV infection.
Lee CA. Lee CA. BMJ. 1992 Mar 7;304(6827):641. doi: 10.1136/bmj.304.6827.641. BMJ. 1992. PMID: 1348441 Free PMC article. No abstract available.

Comment on

High potency factor VIII concentrates: value not proved?
Cash JD. Cash JD. BMJ. 1991 Sep 14;303(6803):633-4. doi: 10.1136/bmj.303.6803.633. BMJ. 1991. PMID: 1932909 Free PMC article. No abstract available.

Similar articles

[Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
Klukowska A, Zieleniewska B. Klukowska A, et al. Acta Haematol Pol. 1994;25(4):349-54. Acta Haematol Pol. 1994. PMID: 7847036 Polish.
Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
de Biasi R, Rocino A, Papa ML, Salerno E, Mastrullo L, De Blasi D. de Biasi R, et al. Thromb Haemost. 1994 May;71(5):544-7. Thromb Haemost. 1994. PMID: 8091377 Clinical Trial.
Hemofil and other factor VIII concentrates.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1969 Nov 14;11(23):96. Med Lett Drugs Ther. 1969. PMID: 5375104 No abstract available.
Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity.
Oldenburg J, Lacroix-Desmazes S, Lillicrap D. Oldenburg J, et al. Haematologica. 2015 Feb;100(2):149-56. doi: 10.3324/haematol.2014.112821. Haematologica. 2015. PMID: 25638804 Free PMC article. Review.
[Recombinant factor VIII concentrate].
Fukutake K. Fukutake K. Rinsho Byori. 1992 Mar;Suppl 92:94-106. Rinsho Byori. 1992. PMID: 1583781 Review. Japanese. No abstract available.

See all similar articles

Cited by

High purity factor VIII concentrates and HIV infection.
Lee CA. Lee CA. BMJ. 1992 Mar 7;304(6827):641. doi: 10.1136/bmj.304.6827.641. BMJ. 1992. PMID: 1348441 Free PMC article. No abstract available.

References

1. BMJ. 1991 Sep 14;303(6803):633-4 - PubMed
1. Lancet. 1991 May 18;337(8751):1222 - PubMed
1. Vox Sang. 1991;60(1):8-15 - PubMed
1. Br J Haematol. 1991 Nov;79(3):457-61 - PubMed
1. Lancet. 1990 Jun 9;335(8702):1403 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information